China Aoxing Given Preferred Status for Cancer Pain Drug

China Aoxing Pharmaceutical Company received “designated manufacturer status” for Tilidine, an opioid medication for cancer pain, from the China State Food & Drug Administration. The designation means China Aoxing will have five years of manufacturing exclusivity for Tilidine. Under present rules, China allows only 13 companies to produce narcotic drugs such as Tilidine, and even more important, only one to three companies are permitted to produce the active pharmaceutical ingredients of the medication. The low-risk business plan of China Aoxing is to introduce Western-style pain drugs to China. More details...

Stock Symbol: (OTCBB: CAXG)